Oxytocin and Major Depressive Disorder: Experimental and Clinical Evidence for Links to Aetiology and Possible Treatment

Author： Slattery David A.   Neumann Inga D.  

Publisher： MDPI

E-ISSN： 1424-8247|3|3|702-724

ISSN： 1424-8247

Source： Pharmaceuticals, Vol.3, Iss.3, 2010-03, pp. : 702-724

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Transcriptomics Evidence for Common Pathways in Human Major Depressive Disorder and Glioblastoma

By Xie Yongfang   Wang Ling   Xie Zengyan   Zeng Chuisheng   Shu Kunxian  

International Journal of Molecular Sciences, Vol. 19, Iss. 1, 2018-01 ,pp. : 234-234

MDPI

Access to resources Recommend Favorite

Atypical Antipsychotics and Other Therapeutic Options for Treatment of Resistant Major Depressive Disorder

By Seo Rubo J.   MacPherson Holly   Young Allan H.  

Pharmaceuticals, Vol. 3, Iss. 12, 2010-12 ,pp. : 3522-3542

MDPI

Access to resources Recommend Favorite

Epigenetic Modifications of Major Depressive Disorder

By Saavedra Kathleen   Molina-Márquez Ana María   Saavedra Nicolás   Zambrano Tomás   Salazar Luis A.  

International Journal of Molecular Sciences, Vol. 17, Iss. 8, 2016-08 ,pp. : 1279-1279

MDPI

Access to resources Recommend Favorite

Cognitive Dysfunction in Major Depressive Disorder. A Translational Review in Animal Models of the Disease

By Darcet Flavie   Gardier Alain M.   Gaillard Raphael   David Denis J.   Guilloux Jean-Philippe  

Pharmaceuticals, Vol. 9, Iss. 1, 2016-02 ,pp. : 9-9

MDPI

Access to resources Recommend Favorite

Pathogenetic and Therapeutic Applications of Tumor Necrosis Factor-α (TNF-α) in Major Depressive Disorder: A Systematic Review

By Ma Ke   Zhang Hongxiu   Baloch Zulqarnain  

International Journal of Molecular Sciences, Vol. 17, Iss. 5, 2016-05 ,pp. : 733-733

MDPI

Access to resources Recommend Favorite